Parenteral Drug Association Inc.

The Parenteral Drug Association Inc., commonly referred to as PDA, is a U.S.-based non-profit organization dedicated to the pharmaceutical and biopharmaceutical industries. Founded in 1946, it operates as an international trade group focused on advancing the science and regulation of parenteral drugs.

Mission and Activities

PDA serves as a global provider of scientific, technological, and regulatory information and education within the pharmaceutical community. It aims to develop and disseminate practical technical knowledge to enhance manufacturing standards and regulatory compliance. Through its efforts, PDA promotes awareness and understanding of critical issues affecting the pharmaceutical and biopharmaceutical sectors.

Membership and Reach

As of recent data, PDA boasts over 10,500 members worldwide, encompassing a diverse range of professionals from 74 countries. This extensive network underscores the organization's role as a leading facilitator of international collaboration and knowledge sharing.

Educational Programs and Conferences

PDA organizes various educational programs and conferences to support continuous training and professional development. Key events include the PDA/FDA Joint Regulatory Conference and the Universe of Pre-Filled Syringes and Injection Devices Conference, which serve as vital platforms for advancing industry practices and regulatory compliance.

Financial and Governance Overview

Parenteral Drug Association Inc. operates under a non-profit framework, with a board of directors comprising industry experts. Its financial operations and governance practices are designed to support its mission of promoting scientific advancement and regulatory understanding in the pharmaceutical industry.

Impact

By providing comprehensive resources and fostering international cooperation, PDA plays a crucial role in ensuring that pharmaceutical and biopharmaceutical products meet high standards of quality and regulatory compliance. This contributes to reducing the risks associated with drug shortages and enhancing patient care globally.

[1] https://en.wikipedia.org/wiki/Parenteral_Drug_Association [2] https://leadiq.com/c/pda---parenteral-drug-association/5a1d82a324000024005d29e8 [3] https://www.europeanpharmaceuticalreview.com/content_hub/52276/parenteral-drug-association-pda/ [4] https://www.guidestar.org/profile/52-1906152 [5] https://www.fiercepharma.com/company/parenteral-drug-association-pda